Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides

Cancer Res. 1997 May 15;57(10):2013-9.

Abstract

Vascular endothelial growth factor (VEGF) increased the level of ETS1 mRNA in human umbilical vein endothelial cells (HUVEC) and human lung microvascular endothelial cells (HMVEC-L) over 5-fold. Protein levels were shown to increase concordantly. VEGF was also found to stimulate the invasiveness of endothelial cells as measured by migration through Matrigel- or gelatin-coated membranes. The VEGF-induced invasiveness was inhibited by ETS1 antisense oligonucleotides but not by a sense control. In addition, the ETS1 antisense oligonucleotides reduced the levels of ETS1 and urokinase-type plasminogen activator mRNAs. The antisense oligonucleotides directed against the ETS1 gene thus altered a cellular property of endothelial cells that is correlated with the ability of the cells to migrate through basement membranes. Together, these observations demonstrate a direct role for the ETS1 gene in angiogenesis.

MeSH terms

  • Cell Division / drug effects
  • Cell Movement / drug effects
  • Cells, Cultured
  • Collagen
  • Drug Combinations
  • Endothelial Growth Factors / antagonists & inhibitors*
  • Endothelial Growth Factors / pharmacology*
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / drug effects*
  • Gelatin
  • Gene Expression / drug effects
  • Gene Expression Regulation / drug effects
  • Humans
  • Laminin
  • Lymphokines / antagonists & inhibitors*
  • Lymphokines / pharmacology*
  • Membranes
  • Oligonucleotides, Antisense / pharmacology*
  • Proteoglycans
  • Proto-Oncogene Protein c-ets-1
  • Proto-Oncogene Proteins / biosynthesis
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-ets
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Stimulation, Chemical
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics*
  • Urokinase-Type Plasminogen Activator / drug effects
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Drug Combinations
  • ETS1 protein, human
  • Endothelial Growth Factors
  • Laminin
  • Lymphokines
  • Oligonucleotides, Antisense
  • Proteoglycans
  • Proto-Oncogene Protein c-ets-1
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-ets
  • RNA, Messenger
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • matrigel
  • Gelatin
  • Collagen
  • Urokinase-Type Plasminogen Activator
  • Tetradecanoylphorbol Acetate